AARP Will Monitor Rx Prices; Association Asks Industry To Help Contain Costs
This article was originally published in The Pink Sheet Daily
Executive Summary
In a letter to 16 pharma companies, AARP CEO Novelli asks manufacturers to "use your influence" to curtail price mark-ups throughout the distribution chain and to support "reasonable" importation legislation.